The first survey of gap between the actual labelling and efficacy information of functional substances in food under the regulatory processes in Japan

Nanae Tanemura, Yusuke Machii, Hisashi Urushihara

研究成果: Article査読

4 被引用数 (Scopus)

抄録

To make well-informed choices, consumers need access to reliable and clear messages regarding the benefits of functional substances in food. This study identified foods with function claims (FFCs) in Japan that had a gap between actual labeling and efficacy information of functional substances not visible on their food package. Between April 1, 2015, to July 20, 2018, 1,310 FFCs were submitted to the regulatory agency and analyzed. The proportion of FFCs with a gap was highest in the health claim category of blood pressure management (79.5%), followed by neutral fat reduction in blood (75%) and suppression of blood sugar spikes (73.4%). These gaps are attributable to differences in food development strategy. Thus, to ensure the quality of benefit communication on FFC to consumers, scientific evidence regarding health claims of functional substances should be managed in an integrated manner.

本文言語English
論文番号104047
ジャーナルJournal of Functional Foods
72
DOI
出版ステータスPublished - 2020 9月

ASJC Scopus subject areas

  • 食品科学
  • 医学(その他)
  • 栄養および糖尿病

フィンガープリント

「The first survey of gap between the actual labelling and efficacy information of functional substances in food under the regulatory processes in Japan」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル